Investors seek safety in bonds, yen after Turkey downs Russian jet
LONDON (Reuters) – Investors sought safety in low-risk government debt on Tuesday after Turkish jets shot down a Russian warplane near the Syrian border, while European tourism-linked stocks fell after a U.S. travel warning due to “increased terrorist …
U.S. retailers hunt for attacks after warning on stealthy malware
BOSTON (Reuters) – U.S. retailers are hunting for evidence of new breaches leading into the holiday shopping season after a cyber intelligence firm privately warned them about payment-card-stealing malware that it said evades almost all security softwa…
Icahn takes stake in Xerox, calls shares ‘undervalued’
(Reuters) – Activist investor Carl Icahn disclosed a stake in Xerox Corp and called the printer and copier maker’s shares “undervalued,” sending the stock up 7.6 percent in extended trade.
Wall Street falls after strong week; Pfizer and Allergan drag
(Reuters) – U.S. stock indexes closed slightly lower in a quiet trading day on Wall Street after last week’s strong gains, while a big healthcare deal failed to impress investors on Monday.
Pfizer to buy Allergan in $160 billion deal
NEW YORK (Reuters) – Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a deal worth $160 billion to slash its U.S. tax bill, rekindling a fierce political debate over the financial maneuver.
Ackman boosts stake in drugmaker Valeant
(Reuters) – Activist investor Bill Ackman’s hedge fund has significantly increased its investment in Valeant Pharmaceuticals International , and signaled it may play a greater role in the beleaguered drugmaker’s strategy, according to a regulatory filing.
Icahn takes stake in Xerox, calls shares ‘undervalued’
(Reuters) – Activist investor Carl Icahn disclosed a stake in Xerox Corp , and called the printer and copier maker’s shares “undervalued”, sending its shares up 7.6 percent in extended trade.
Exclusive: ValueAct gains for the year wiped out by Valeant loss
(Reuters) – Activist investor ValueAct Capital said its fund fell 8.3 percent during the third quarter, wiping out its gains for the year, hurt by a plunge in shares of its main portfolio company, Valeant Pharmaceuticals International Inc .
Fed’s Yellen argues for interest rate caution in exchange with Nader
WASHINGTON (Reuters) – Federal Reserve Chair Janet Yellen on Monday argued for a cautious approach to the pace of interest rises in an unusual exchange with U.S. consumer advocate Ralph Nader.
Wall Street falls after strong week; Pfizer and Allergan drag
(Reuters) – U.S. stock indexes closed slightly lower in a quiet trading day on Wall Street after last week’s strong gains, while a big healthcare deal failed to impress investors on Monday.
